Lehrstuhl für Molekulare Psychiatrie
Refine
Has Fulltext
- yes (5)
Is part of the Bibliography
- yes (5)
Year of publication
- 2015 (5) (remove)
Document Type
- Journal article (4)
- Doctoral Thesis (1)
Keywords
- 5-HTT (1)
- CB1 receptor antagonists (1)
- Furchtkonditionierung (1)
- Hippocampus (1)
- NMDA receptor subunits NR2A and NR2B (1)
- Serotonin (1)
- T-cadherin (1)
- aging (1)
- allostatic load (1)
- animal behavior (1)
Institute
Cadherin-13 (CDH13), a unique glycosylphosphatidylinositol-anchored member of the cadherin family of cell adhesion molecules, has been identified as a risk gene for attention-deficit/hyperactivity disorder (ADHD) and various comorbid neurodevelopmental and psychiatric conditions, including depression, substance abuse, autism spectrum disorder and violent behavior, while the mechanism whereby CDH13 dysfunction influences pathogenesis of neuropsychiatric disorders remains elusive. Here we explored the potential role of CDH13 in the inhibitory modulation of brain activity by investigating synaptic function of GABAergic interneurons. Cellular and subcellular distribution of CDH13 was analyzed in the murine hippocampus and a mouse model with a targeted inactivation of Cdh13 was generated to evaluate how CDH13 modulates synaptic activity of hippocampal interneurons and behavioral domains related to psychopathologic (endo) phenotypes. We show that CDH13 expression in the cornu ammonis (CA) region of the hippocampus is confined to distinct classes of interneurons. Specifically, CDH13 is expressed by numerous parvalbumin and somatostatin-expressing interneurons located in the stratum oriens, where it localizes to both the soma and the presynaptic compartment. Cdh13\(^{-/-}\) mice show an increase in basal inhibitory, but not excitatory, synaptic transmission in CA1 pyramidal neurons. Associated with these alterations in hippocampal function, Cdh13\(^{-/-}\) mice display deficits in learning and memory. Taken together, our results indicate that CDH13 is a negative regulator of inhibitory synapses in the hippocampus, and provide insights into how CDH13 dysfunction may contribute to the excitatory/inhibitory imbalance observed in neurodevelopmental disorders, such as ADHD and autism.
Central insulin receptor-mediated signaling is attracting the growing attention of researchers because of rapidly accumulating evidence implicating it in the mechanisms of plasticity, stress response, and neuropsychiatric disorders including depression. Dicholine succinate (DS), a mitochondrial complex II substrate, was shown to enhance insulin-receptor mediated signaling in neurons and is regarded as a sensitizer of the neuronal insulin receptor. Compounds enhancing neuronal insulin receptor-mediated transmission exert an antidepressant-like effect in several pre-clinical paradigms of depression; similarly, such properties for DS were found with a stress-induced anhedonia model. Here, we additionally studied the effects of DS on several variables which were ameliorated by other insulin receptor sensitizers in mice. Pre-treatment with DS of chronically stressed C57BL6 mice rescued normal contextual fear conditioning, hippocampal gene expression of NMDA receptor subunit NR2A, the NR2A/NR2B ratio and increased REM sleep rebound after acute predation. In 18-month-old C57BL6 mice, a model of elderly depression, DS restored normal sucrose preference and activated the expression of neural plasticity factors in the hippocampus as shown by Illumina microarray. Finally, young naive DS-treated C57BL6 mice had reduced depressive- and anxiety-like behaviors and, similarly to imipramine-treated mice, preserved hippocampal levels of the phosphorylated (inactive) form of GSK3 beta that was lowered by forced swimming in pharmacologically naive animals. Thus, DS can ameliorate behavioral and molecular outcomes under a variety of stress- and depression-related conditions. This further highlights neuronal insulin signaling as a new factor of pathogenesis and a potential pharmacotherapy of affective pathologies.
Behavioral profiles are influenced by both positive and negative experiences as well as the genetic disposition. Traditionally, accumulating adversity over lifetime is considered to predict increased anxiety like behavior ("allostatic load"). The alternative "mismatch hypothesis" suggests increased levels of anxiety if the early environment differs from the later-life environment. Thus, there is a need for a whole-life history approach to gain a deeper understanding of how behavioral profiles are shaped. The aim of this study was to elucidate the effects of life history on the behavioral profile of mice varying in serotonin transporter (5-HIT) genotype, an established mouse model of increased anxiety-like behavior. For this purpose, mice grew up under either adverse or beneficial conditions during early phases of life. In adulthood, they were further subdivided so as to face a situation that either matched or mismatched the condition experienced so far, resulting in four different life histories. Subsequently, mice were tested for their anxiety-like and exploratory behavior. The main results were: (1) Life history profoundly modulated the behavioral profile. Surprisingly, mice that experienced early beneficial and later escapable adverse conditions showed less anxiety-like and more exploratory behavior compared to mice of other life histories. (2) Genotype significantly influenced the behavioral profile, with homozygous 5-HTT knockout mice displaying highest levels of anxiety-like and lowest levels of exploratory behavior. Our findings concerning life history indicate that the absence of adversity does not necessarily cause lower levels of anxiety than accumulating adversity. Rather, some adversity may be beneficial, particularly when following positive events. Altogether, we conclude that for an understanding of behavioral profiles, it is not sufficient to look at experiences during single phases of life, but the whole life history has to be considered.
Background
Although 5-HTTLPR has been shown to influence the risk of life stress-induced depression in the majority of studies, others have produced contradictory results, possibly due to weak effects and/or sample heterogeneity.
Methods
In the present study we investigated how age, type and intensity of life-stressors modulate the effect of 5-HTTLPR on depression and anxiety in a European population cohort of over 2300 subjects. Recent negative life events (RLE), childhood adversity (CHA), lifetime depression, Brief Symptoms Inventory (BSI) depression and anxiety scores were determined in each subject. Besides traditional statistical analysis we calculated Bayesian effect strength and relevance of 5-HTTLPR genotypes in specified models.
Results
The short (s) low expressing allele showed association with increased risk of depression related phenotypes, but all nominally significant effects would turn to non-significant after correction for multiple testing in the traditional analysis. Bayesian effect strength and relevance analysis, however, confirmed the role of 5-HTTLPR. Regarding current (BSI) and lifetime depression 5-HTTLPR-by-RLE interactions were confirmed. Main effect, with other words direct association, was supported with BSI anxiety. With more frequent RLE the prevalence or symptoms of depression increased in ss carriers. Although CHA failed to show an interaction with 5-HTTLPR, in young subjects CHA sensitized towards the depression promoting effect of even mild RLE. Furthermore, the direct association of anxiety with the s allele was driven by young (\(\leq\)30) individuals.
Limitations
Our study is cross-sectional and applies self-report questionnaires.
Conclusions
Albeit 5-HTTLPR has only weak/moderate effects, the s allele is directly associated with anxiety and modulates development of depression in homogeneous subgroups.
Veränderungen des zentralen serotonergen Systems können mit diversen psychiatrischen Krankheiten wie z. B. Depressionen, Aufmerksamkeitsdefizit/ Hyperaktivitäts-Störung (ADHS), Phobien oder Panik- und Angststörungen assoziiert werden. Die fortlaufende Untersuchung des Neurotransmitters Serotonin (5-HT) und seine Bedeutung für physiologische und verhaltens- bezogene Prozesse ist daher unerlässlich. Tiermodelle, die auf Ausschaltung elementarer oder assoziierter Gene des serotonergen Systems beruhen, sind infolgedessen eine ausgezeichnete Möglichkeit anatomische, (patho)physiolo- gische und verhaltensbezogene Auswirkungen eines fehlgeleiteten serotoner- gen Systems zu untersuchen und zu analysieren. Aufgrund ihrer großen Be- deutung für Lern- und Gedächtnisprozesse steht die Hirnregion des dorsalen Hippocampus im Fokus dieser Dissertation. Die Analyse umfasste jeweils die gesamte Hirnstruktur des Hippocampus bzw. seine Unterregionen, Gyrus dentatus (DG), Cornu Ammonis (CA)1 und CA3.
Die Zielsetzung dieser Arbeit war die Untersuchung zellulärer bzw. molekularer Veränderungen von konstitutiven Tryptophanhydroxylase 2 (Tph2) knockout (KO) Mäusen. Durch die Inaktivierung von Tph2 und damit dem geschwindig- keitsbestimmenden Enzym (TPH2) der Serotoninsynthese, wurde im zentralen Nervensystem (ZNS) der KO Mäuse ein Mangel von 5-HT festgestellt. Der dorsale Hippocampus wurde auf zellspezifische Veränderungen nach dem Furchtkonditionierungstest analysiert. Die Reaktion der Neurone in den drei Unterregionen der Hirnstruktur wurde durch Immunofluoreszenzfärbung des „immediate-early“ Genprodukts c-fos bzw. des Calcium-bindenden Proteins Parvalbumin untersucht. Es wurde dabei zum einen die absolute Zellzahl in den Strukturen erfasst und zum anderen die Analyse bezüglich des Volumens vorgenommen. Die Zelldichte von c-Fos wies signifikante Unterschiede zwischen den Gruppen im gesamten dorsalen Hippocampus und bei genauerer Betrachtung in der Unterregion des DG auf. Die Tph2-/- Mäuse zeigten nach dem Furchtkonditionierungstest eine prägnante Erhöhung der aktivierten Zellen. Es scheint, dass 5-HT eine zu starke Aktivierung des dorsalen Hippocampus verhindert um schlechte kontextbezogene Gedächtnisinhalte nicht zu verfesti- gen. Dabei inhibiert 5-HT Zellen im DG und der CA1 Region die nicht zu den Parvalbumin-immunoreaktiven GABAergen Interneuronen gehören.